Characterization of the Neoantigen Profile in a Tumor Mutation Burden-high Melanoma Patient With Multiple Metastases
These results might suggest that the heterogeneity of driver gene mutations is unremarkable, while immunological response is variable in metastatic sites. As a result, the genomic and immunological investigation has provided a very valuable and informative suggestion regarding better cancer therapy decisions.
Authors
- Kenichi Urakami (ORCID: https://orcid.org/0000-0002-4751-0978)
- Chie Maeda
- Yoshio Kiyohara (ORCID: https://orcid.org/0000-0001-7335-4617)
- Akira Iizuka (ORCID: https://orcid.org/0000-0002-2545-5138)
- Tadashi Ashizawa
- Akari Kanematsu
- Takeshi Nagashima (ORCID: https://orcid.org/0000-0002-7261-9908)
- Yasufumi Kikuchi (ORCID: https://orcid.org/0009-0000-3447-8342)
- Yasuto Akiyama (ORCID: https://orcid.org/0000-0003-3813-7726)
- Ken Yamaguchi (ORCID: https://orcid.org/0000-0002-9893-7218)
- Keiichi Ohshima (ORCID: https://orcid.org/0000-0002-2882-7566)
- Tomoatsu Ikeya
- Haruo Miyata
- Kazue Yamashita
- Shusuke Yoshikawa (ORCID: https://orcid.org/0009-0002-6082-4696)
Institutions
- Shizuoka Cancer Center (JP)
- SRL (Japan) (JP)
Publication Details
- Journal
- Cancer Genomics & Proteomics
- Published
- 2025-04-25
- DOI
- https://doi.org/10.21873/cgp.20517
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05